Evidence map›Paper›PMID 27008570›Full record

ArticleACS chemical biology2016

Site-Specific Radiofluorination of Biomolecules with 8-[(18)F]-Fluorooctanoic Acid Catalyzed by Lipoic Acid Ligase.

Christopher R Drake, Natalia Sevillano, Charles Truillet, Charles S Craik, Henry F VanBrocklin, Michael J Evans

Abstract read
In one paragraph

Article in ACS chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Promiscuous Enzymes for Residue-Specific Peptide and Protein Late-Stage Functionalization.Chembiochem : a European journal of chemical biology · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Nanobodies as non-invasive imaging tools.Immuno-oncology technology · 2020
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Chemistry (Weinheim an der Bergstrasse, Germany) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christopher R DrakeDepartment of Radiology and Biomedical Imaging, University of California San Francisco , Suite 350, 185 Berry Street, San Francisco, California 94107, United States.
Natalia SevillanoDepartment of Pharmaceutical Chemistry, University of California San Francisco , Genentech Hall, S-514, 600 16th Street, San Francisco, California 94158, United States.
Charles TruilletDepartment of Radiology and Biomedical Imaging, University of California San Francisco , Suite 350, 185 Berry Street, San Francisco, California 94107, United States.
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California San Francisco , Genentech Hall, S-514, 600 16th Street, San Francisco, California 94158, United States.
Henry F VanBrocklinDepartment of Radiology and Biomedical Imaging, University of California San Francisco , Suite 350, 185 Berry Street, San Francisco, California 94107, United States.
Michael J EvansDepartment of Radiology and Biomedical Imaging, University of California San Francisco , Suite 350, 185 Berry Street, San Francisco, California 94107, United States.
University of California, San Francisco · USUniversity of California System · US

Funding

Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Renewable antibodies to secreted proteins and single and multi-pass cell surfaceP41CA196276 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2014 to 2018
$5.8M
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PETR01CA176671 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI EVANS, MICHAEL JOHN, LEWIS, JASON S. · 2013 to 2017
$3.1M
Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrinR00CA172695 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EVANS, MICHAEL JOHN · 2014 to 2016
$728k
National Institute of Health 1P4CA1962276-01NCI NIH HHS P41 CA196276NCI NIH HHS R00 CA172695NCI NIH HHS R01 CA176671NIGMS NIH HHS P41 GM103481
6 · The paper itself

Abstract

New methodologies for site-specifically radiolabeling proteins with (18)F are required to generate high quality radiotracers for preclinical and clinical applications with positron emission tomography. Herein, we report an approach by which we use lipoic acid ligase (LplA) to conjugate [(18)F]-fluorooctanoic acid to an antibody fragment bearing the peptide substrate of LplA. The mild conditions of the reaction preserve antibody immunoreactivity, and the efficiency of LplA allows for >90% yield even with very small amounts of peptidic precursor (1-10 nmol). These features are advantageous compared to the current gold standard in the field. Moreover, the methodology introduces a new application for an important tool in chemical biology.

Indexed as

CaprylatesEscherichia coli ProteinsFluorine RadioisotopesHalogenationHEK293 CellsHumansImmunoglobulin Fab FragmentsLigasesPeptides8-fluorooctanoic acidCaprylatesEscherichia coli ProteinsFluorine RadioisotopesImmunoglobulin Fab FragmentsLigaseslplA protein, E coliPeptides

Identifiers

PMID27008570
PMCPMC5712215
OpenAlexW4247962372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.